Trials / Sponsors / The Deutsche Diabetes Forschungsgesellschaft e.V.
The Deutsche Diabetes Forschungsgesellschaft e.V.
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients with Type 2 Diabetes Type2 Diabetes | Phase 2 | 2022-01-07 |
| Completed | Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Type 2 Diabetes, Non-alcoholic Fatty Liver Disease | Phase 4 | 2015-12-01 |